| human | Q5 |
| P496 | ORCID iD | 0000-0001-6826-7893 |
| P3829 | Publons author ID | 2133066 |
| P1053 | ResearcherID | E-8771-2017 |
| P1153 | Scopus author ID | 15750100700 |
| P108 | employer | National Cancer Institute | Q3747179 |
| P735 | given name | Carlo | Q4205426 |
| Carlo | Q4205426 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q34579605 | A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis. |
| Q53405751 | CT cholangiography: assessment of feasibility and diagnostic reliability. |
| Q33820376 | Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma |
| Q51499838 | DNA methylation-based prognosis and epidrivers in hepatocellular carcinoma. |
| Q40521529 | Development of a prognostic scoring system for resectable hepatocellular carcinoma |
| Q33594457 | Massive APOBEC3 editing of hepatitis B viral DNA in cirrhosis |
| Q37183244 | Pivotal role of mTOR signaling in hepatocellular carcinoma |
| Q34551964 | Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study |
| Q57100049 | Simultaneous characterization of progenitor cell compartments in adult human liver |
| Q24646374 | miR-221 overexpression contributes to liver tumorigenesis |
Search more.